Quest Diagnostics (DGX) Tops Q2 EPS by 12c; Raises Outlook
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $235.52 +0.48%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $2.36, $0.12 better than the analyst estimate of $2.24. Revenue for the quarter came in at $2.45 billion versus the consensus estimate of $2.32 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.55-$9.95, versus the consensus of $9.33.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
